SEC Filings for Clementia Pharmaceuticals Inc. (CMTA)

$ N/A N/A (N/A) Volume: 0 N/A
Filing Type:
Form TypeForm DescriptionPagesDateView
15-12BTermination of registration under Section 12(b) or suspension of duty to file reports204/29/2019
25-NSENotification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities104/18/2019
S-8 POSPost-effective amendment to an S-8 filing304/18/2019
POS AMPost-effective amendment to an S-Type filing304/18/2019
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act604/18/2019
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act404/11/2019
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act404/09/2019
20-FAnnual and transition report of foreign private issuers under sections 13 or 15(d)42303/29/2019
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act16503/13/2019
SC 13DFiling by person(s) reporting owned shares of common stock in a public company >5%2103/13/2019
SC 13DFiling by person(s) reporting owned shares of common stock in a public company >5%1303/06/2019
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act2903/06/2019
SC 13D/AAmendment to a SC 13D filing1003/01/2019
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act402/28/2019
<<
First
<
Prev
1234567